Athlone Laboratories Limited
Karl Duke is an accomplished financial professional with extensive experience in financial management and accounting across various industries. Currently serving as Financial Controller at Athlone Laboratories Limited since July 2021, Karl oversees site financial functions and deliverables. Previous roles include Financial Controller at Pat The Baker, where responsibilities encompassed multi-company management accounts and team leadership, as well as Financial Manager positions at Fannin Ltd and Alkermes, focusing on cost models and operational excellence initiatives. Karl's career includes lecturing at Athlone Institute of Technology and key finance roles at notable companies such as Elan Pharma International Ltd., Medtronic, and Zurich Insurance Company Ltd. Educational achievements include an ACCA qualification and an MBA from Technological University of the Shannon.
This person is not in any teams
Athlone Laboratories Limited
Athlone Laboratories is a leading European developer, manufacturer and exporter of a broad range of oral dose beta-lactam products. Established in the Republic of Ireland in 1974, the company is an accredited supplier to local and many blue-chip customer partners across Europe, Asia-Pacific, Canada, Israel, Iraq, Brazil and others. Athlone Laboratories is part of the newly formed Kent Athlone Pharma Group since September 2019. Athlone is also a proud member of https://www.amrindustryalliance.org/